'Pharma Bro' Martin Shkreli's Trial Begins
Update RequiredTo play audio, update browser or
Flash plugin.
Martin Shkreli arrives at Brooklyn Federal Court on the first day of his securities fraud trial on June 26, 2017 in Brooklyn, N.Y. (Kevin Hagen/Getty Images)
Former pharmaceutical CEO Martin Shkreli goes on trial starting Monday for federal securities fraud. Shkreli, who became known as “pharma bro,” came under widespread criticism for upping the price of the lifesaving drug Daraprim 5,000 percent. He is going on trial for something unrelated — prosecutors say that he operated a Ponzi-like scheme at two companies he ran.
Here & Now‘s Jeremy Hobson speaks with MSNBC’s Ali Velshi (@AliVelshi) about what’s expected in the trial.
Copyright 2024 NPR. To see more, visit https://www.npr.org.
View this story on npr.org
Follow us for more stories like this
CapRadio provides a trusted source of news because of you. As a nonprofit organization, donations from people like you sustain the journalism that allows us to discover stories that are important to our audience. If you believe in what we do and support our mission, please donate today.
Donate Today